<root>
	<PMID Version="1">25560175</PMID>
	<Summary>
		1: Barrow TM, Barault L, Ellsworth RE, Harris HR, Binder AM, Valente AL, Shriver CD, Michels KB. Aberrant methylation of imprinted genes is associated withnegative hormone receptor status in invasive breast cancer. Int J Cancer. 2015Aug 1;137(3):537-47. doi: 10.1002/ijc.29419. Epub 2015 Jan 21. PubMed PMID:25560175; PubMed Central PMCID: PMC4437845.
	</Summary>
	<MeshHeadingList>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D000483">Alleles</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D001941">Breast Diseases</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D001943">Breast Neoplasms</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D019175">DNA Methylation</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D044127">Epigenesis, Genetic</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D051383">GRB10 Adaptor Protein</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015870">Gene Expression</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015972">Gene Expression Regulation, Neoplastic</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="Y" UI="D018392">Genomic Imprinting</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D007335">Insulin-Like Growth Factor II</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D009361">Neoplasm Invasiveness</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D009367">Neoplasm Staging</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D018719">Receptor, ErbB-2</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D011960">Receptors, Estrogen</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D011980">Receptors, Progesterone</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000235">genetics</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
	    </MeshHeading>
	</MeshHeadingList>
</root>
